Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1978 Aug;37(4):366–369. doi: 10.1136/ard.37.4.366

Neutropenia during treatment of rheumatoid arthritis with levamisole.

G T Williams, S A Johnson, P A Dieppe, E C Huskisson
PMCID: PMC1000246  PMID: 686870

Abstract

Of 60 patients with rheumatoid arthritis treated with levamisole 35% showed a persistent decrease in neutrophil counts from pre-treatment levels and 6 (10%) develped severe neutropenia of less than 1.0 X 10(9)/1. One of these neutropenic patients recoverd without stopping therapy and the other 5 patients recovered rapidly when the drug was withdrawn. In some patients neutropenia recurred on reinstitution of levamisole.

Full text

PDF
369

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clara R., Germanes J. Levamisole and agranolocytosis. Lancet. 1977 Jan 1;1(8001):47–48. doi: 10.1016/s0140-6736(77)91688-9. [DOI] [PubMed] [Google Scholar]
  2. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association. Ann Rheum Dis. 1959 Mar;18(1):49–53. [PMC free article] [PubMed] [Google Scholar]
  3. Gordon M. Y., Blackett N. M., Douglas I. D. Colony formation by human haemopoietic precursor cells cultured in semi-solid agar in diffusion chambers. Br J Haematol. 1975 Sep;31(1):103–110. doi: 10.1111/j.1365-2141.1975.tb00837.x. [DOI] [PubMed] [Google Scholar]
  4. Hurd E. R., Ziff M. Parameters of improvement in patients with rheumatoid arthritis treated with cyclophosphamide. Arthritis Rheum. 1974 Jan-Feb;17(1):72–78. doi: 10.1002/art.1780170111. [DOI] [PubMed] [Google Scholar]
  5. Huskisson E. C., Scott J., Balme H. W., Dieppe P. A., Trapnell J., Willoughby D. A. Immunostimulant therapy with levamisole for rheumatoid arthritis. Lancet. 1976 Feb 21;1(7956):393–395. doi: 10.1016/s0140-6736(76)90218-x. [DOI] [PubMed] [Google Scholar]
  6. Lehner T., Wilton J. M., Ivanyi L. Double blind crossover trial of levamisole in recurrent aphthous ulceration. Lancet. 1976 Oct 30;2(7992):926–929. doi: 10.1016/s0140-6736(76)90891-6. [DOI] [PubMed] [Google Scholar]
  7. Rojas A. F., Feierstein J. N., Mickiewicz E., Glait H., Olivari A. J. Levamisole in advanced human breast cancer. Lancet. 1976 Jan 31;1(7953):211–215. doi: 10.1016/s0140-6736(76)91337-4. [DOI] [PubMed] [Google Scholar]
  8. Rosenthal M., Trabert U., Müller W. Immunotherapy with levamisole in rheumatic diseases. Scand J Rheumatol. 1976;5(4):216–220. doi: 10.3109/03009747609099908. [DOI] [PubMed] [Google Scholar]
  9. Rosenthal M., Trabert U., Müller W. Letter: Leucocytotoxic effect of levamisole. Lancet. 1976 Feb 14;1(7955):369–369. doi: 10.1016/s0140-6736(76)90133-1. [DOI] [PubMed] [Google Scholar]
  10. Ruuskanen O., Remes M., Mäkela A. L., Isomäki H., Toivanen A. Levamisole and agranulocytosis. Lancet. 1976 Oct 30;2(7992):958–959. doi: 10.1016/s0140-6736(76)90916-8. [DOI] [PubMed] [Google Scholar]
  11. Sany J., Morlack G., Kalfa G., Serre H. Agranulocytose au cours de traitement par lévamisole. Nouv Presse Med. 1976 Apr 24;5(17):1148–1148. [PubMed] [Google Scholar]
  12. Scott J., Huskisson E. C. Graphic representation of pain. Pain. 1976 Jun;2(2):175–184. [PubMed] [Google Scholar]
  13. Vanholder R., Van Hove W. Recurrent agranulocytosis after levamisole. Lancet. 1977 Jan 8;1(8002):100–100. doi: 10.1016/s0140-6736(77)91119-9. [DOI] [PubMed] [Google Scholar]
  14. Williams I. A. Letter: Levamisole and agranulocytosis. Lancet. 1976 May 15;1(7968):1080–1081. doi: 10.1016/s0140-6736(76)92261-3. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES